Showing results (161-170 of 194) with videos related to
Sort By:
Pageof 20
Scientific Reports|November 3, 2024
Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective studyMaëna Le Corvec, Marwin A Farrugia, Eric Nguyen-Khac, et al.Gastroenterology|August 26, 2018
Effects of Long-term Norfloxacin Therapy in Patients With Advanced CirrhosisRichard Moreau, Laure Elkrief, Christophe Bureau, et al.BMC Infectious Diseases|April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohortAnne Laurain, Sophie Metivier, Georges Haour, et al.Hepatology (Baltimore, Md.)|April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitisJean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.Gastroenterology|March 23, 2002
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter studyRichard Moreau, Francois Durand, Thierry Poynard, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF CohortManon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, et al.Oncotarget|October 4, 2017
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver diseaseAbderrahim Oussalah, Patrice Hodonou Avogbe, Erwan Guyot, et al.European Journal of Gastroenterology & Hepatology|August 13, 2025
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapyEric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, et al.The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.Journal of Hepatology|September 14, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsStanislas Pol, Marc Bourliere, Sandy Lucier, et al.Pageof 20